We implemented a customer payment deferral program (principal and interest) to assist business borrowers and certain consumers that may be experiencing financial hardship due to COVID-19 related challenges. These loans will continue to accrue interest during the deferral period unless otherwise classified as nonaccrual. Consistent with the CARES Act and regulatory guidance, borrowers that were otherwise current on loan payments that were granted COVID-19 related financial hardship payment deferrals will continue to be reported as current loans throughout the agreed upon deferral period. There were no delinquent loans upon adoption of our payment deferral program. The following table provides information regarding payment deferral loans.
| | | | | | | | | |
| As of April 1, 2021 | |
| | | | | | Weighted Average | | Weighted Average | |
| Number of | | | Loan | | Debt Service | | Loan to | |
| Borrowers | | | Balance | | Coverage | | Value Ratio | |
|
| (Dollars in thousands) | |
1 – 4 family | 2 | | $ | 8,415 | | 1.39x | | 70 | % |
Multifamily | 1 | | | 4,244 | | 1.27x | | 61 | |
Commercial real estate | 1 | | | 3,701 | | 1.16x | | 64 | |
Total | 4 | | $ | 16,360 | | | | | |
As of April 1, 2021, the Company had four borrowers on payment deferral reducing the programs total loan balance by $16.4 million from $32.8 million as of March 31, 2021. As of April 1, 2021, a total of four borrowers with aggregate loan principal balances totaling $16.4 million, or approximately 2.3% of our total loan portfolio, are participating in the payment deferral program. This is a decrease of $12.8 million from the December 31, 2020 balance of $29.2 million. To date, none of the borrowers that have participated in the payment deferral program received loan modifications qualifying as a TDR nor have they been placed on nonperforming status.
As previously disclosed, we believe the revisions to various claims administration protocols surrounding potential claims of fraud and the ongoing effects of the pandemic has extended the duration of our NFL post settlement loan portfolio. Specifically, the current uncertainty related to our borrowers’ (“claimants”) access to qualified testing, doctors, their attorneys and other administrative support, has introduced incremental duration risk which may further extend the settlement of claims and payoff of our NFL loans beyond the contractual maturity. The Company ceased NFL loan originations in December 2017. At March 31, 2021, NFL consumer loan exposure totaled $24.1 million with a weighted average life of approximately one year. The Company increased its general allowance allocation to consumer loans to $5.0 million, or 14.1%, as of March 31, 2021, as compared to $1.0 million, or 2.2%, of the consumer portfolio as of March 31, 2020.
From a payment processing perspective, we have taken action to identify and assess our COVID-19 related credit exposure, primarily defined as merchant returns and chargebacks, by merchant industry type and category. These industry types include, but are not limited to, restaurants, hospitality, travel and entertainment. We have also assessed the level and adequacy of our ISO and merchant reserves held on deposit at Esquire Bank. Currently, based on this assessment, we have not identified any elevated credit risk in these affected industry types and other categories and our return and chargeback ratios remain relatively consistent with pre-COVID-19 levels.
The COVID-19 pandemic may continue to impact our financial results and demand for our products and services during the remainder of 2021 and potentially beyond. The short and long-term implications of this healthcare and economic crisis may continue to affect our revenues, earnings results, allowance for loan losses, capital reserves, and liquidity in the future.
Comparison of Financial Condition at March 31, 2021 and December 31, 2020
Assets. Our total assets were $998.3 million at March 31, 2021, an increase of $61.6 million, or 6.6%, from $936.7 million at December 31, 2020, primarily due to increases in loans of $30.4 million, or 4.5%, cash and cash equivalents of $22.7 million, or 34.8%, and securities available for sale of $13.9 million, or 11.8%.